Venlafaxine Treatment and Risk of Discontinuation Syndrome N389B
Venlafaxine is an FDA-approved first-line treatment for major depressive disorder (MDD) and anxiety disorders. Therapeutic effects result from its action as a Read more…
Venlafaxine is an FDA-approved first-line treatment for major depressive disorder (MDD) and anxiety disorders. Therapeutic effects result from its action as a Read more…
Gabapentin is a multipurpose medication that enhances GABAergic effects, inhibits excitatory neuronal signaling, and effectively prevents seizures. The U.S. Food and Drug Read more…
Beta-blockers are a diverse class of medications primarily used to manage cardiovascular conditions such as hypertension, angina pectoris, arrhythmias, and heart failure. Read more…
Pimozide is a first-generation antipsychotic primarily indicated for the treatment of severe, refractory tics in Tourette syndrome (TS). With a pharmacological profile Read more…
Topiramate is a drug that has been widely studied for the treatment of various psychiatric and neurological disorders, particularly epilepsy, as well Read more…
Pregabalin, a gamma-aminobutyric acid (GABA) analogue, is widely used for managing neuropathic pain, fibromyalgia, partial-onset seizures, and various off-label conditions such as Read more…
An opioid use disorder is a complex process that is caused by repeated exposure to opioids, and there are genetic, psychological, social, Read more…
Acetaminophen poisoning is a leading cause of drug-induced liver injury in the United States, often resulting from unintentional overdoses or intentional ingestion. Read more…
Treating pain encompasses many challenges, legal considerations, and strategic approaches. Challenges include accurately diagnosing pain, especially considering its subjective nature, and addressing Read more…
Prazosin, an alpha-1 adrenergic receptor antagonist, is primarily indicated for the treatment of hypertension by blocking excessive norepinephrine responsiveness at postsynaptic α1 Read more…